There were 1,257 press releases posted in the last 24 hours and 429,724 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
FDA approves selumetinib for pediatric patients 1 year of age and older with neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image